Gainers
- Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64.
- Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.
- Fast Radius, Inc. (NASDAQ: FSRD) jumped 41.2% to close at $0.8887 after jumping over 37% on Thursday. Fast Radius recently appointed Pat McCusker as President, Interim CFO and John Nanry as COO.
- Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) jumped 36.5% to close at $3.55.
- Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares jumped 36.2% to close at $0.6131 on Friday after dropping 10% on Thursday.
- Inter & Co, Inc. (NASDAQ: INTR) jumped 31.9% to close at $2.77. Goldman Sachs (NYSE:GS) recently initiated coverage on the stock with a Sell rating.
- Shift Technologies, Inc. (NASDAQ: SFT) jumped 28.9% to close at $0.8676 after declining around 7% on Thursday.
- Accolade, Inc. (NASDAQ: ACCD) climbed 28.8% to close at $9.53 after the company reported better-than-expected Q1 results.
- Mega Matrix Corp. (NASDAQ: MTMT) gained 25.7% to close at $1.71.
- Aspira Women's Health Inc. (NASDAQ: AWH) climbed 24.7% to close at $0.7324.
- Mereo BioPharma Group plc (NASDAQ: MREO) rose 24.1% to settle at $1.39.
- Tuniu Corporation (NASDAQ: TOUR) gained 23.8% to close at $1.30.
- Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares gained 23.1% to close at $5.12. Lytus recently announced the closing of initial public offering.
- Endo International plc (NASDAQ: ENDP) jumped 22.4% to close at $0.5701 after a federal jury in Chicago returned a verdict in favor of the Company in the Opana ER antitrust trial.
- Belite Bio, Inc (NASDAQ: BLTE) gained 21% to close at $37.69 after Benchmark initiated coverage on the stock with a Buy rating and $57 price target.
- Zhong Yang Financial Group Limited (NASDAQ: TOP) gained 20.7% to settle at $29.80.
- Indaptus Therapeutics, Inc. (NASDAQ: INDP) rose 19.9% to close at $3.13.
- Betterware de México, S.A.P.I. de C.V. (NASDAQ: BWMX) jumped 19.3% to close at $10.31.
- INVO Bioscience, Inc. (NASDAQ: INVO) gained 19% to close at $0.7840.
- Yatsen Holding Limited (NYSE: YSG) jumped 18.1% to close at $1.83.
- Coupang, Inc. (NYSE: CPNG) jumped 18% to close at $15.04 after Credit Suisse (SIX:CSGN) upgraded the stock from Neutral to Outperform.
- VerifyMe, Inc. (NASDAQ: VRME) shares rose 17.4% to close at $2.30 after the company announced liquidation of the G3 VRM Acquisition SPAC and initiated a new share repurchase program.
- Tyra Biosciences, Inc. (NASDAQ: TYRA) jumped 17.2% to settle at $8.38.
- 2U, Inc. (NASDAQ: TWOU) gained 17% to close at $12.25. Byju's recently reportedly made an offer to acquire the company for $15 per share.
- Gravitas Education Holdings, Inc. (NYSE: GEHI) gained 16.8% to close at $0.69.
- Alvotech (NASDAQ: ALVO) gained 16.3% to close at $9.55. Deutsche Bank (ETR:DBKGn) initiated coverage on Alvotech with a Hold rating and announced a price target of $10.
- FedNat Holding Company (NASDAQ: FNHC) surged 16.1% to settle at $0.36.
- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) gained 16.1% to close at $1.37.
- Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH) jumped 16% to close at $2.47.
- BioRestorative Therapies, Inc. (NASDAQ: BRTX) surged 14.8% to close at $3.4195. BioRestorative Therapies recently enrolled first patient in the phase 2 clinical study of its lead drug BRTX-100 in chronic lumbar disc disease (cLDD).
- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) gained 14.3% to close at $1.60.
- Engine Gaming and Media, Inc. (NASDAQ: GAME) gained 12.1% to close at $0.9078.
- Panbela Therapeutics, Inc. (NASDAQ: PBLA) jumped 12.1% to close at $0.74.
- Sonder Holdings Inc. (NASDAQ: SOND) shares surged 11.5% to close at $1.16.
- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) gained 11% to close at $0.2120. Allena Pharmaceuticals recently announced it has terminated its previously announced at-the-market offering.
- LightInTheBox Holding Co., Ltd. (NYSE: LITB) rose 10.4% to close at $1.06. LightInTheBox recently posted Q1 sales of $93.77 million.
- Akebia Therapeutics, Inc. (NASDAQ: AKBA) rose 10.2% to close at $2.77 after the company executed an agreement to terminate its vadadustat Collaboration and License Agreements with Otsuka Pharmaceutical. The company will receive a $55 million settlement fee.
- Larimar Therapeutics, Inc. (NASDAQ: LRMR) gained 9.7% to close at $2.15.
- Etsy, Inc. (NASDAQ: ETSY) surged 9% to close at $79.81. Evercore ISI Group maintained Etsy with an Outperform and lowered the price target from $130 to $95.
- ECMOHO Limited (NASDAQ: MOHO) gained 8.8% to close at $0.1787 after dropping over 4% on Thursday.
- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) gained 8.6% to close at $1.89.
- Cosmos Holdings Inc. (NASDAQ: COSM) rose 8.6% to settle at $0.4060. Cosmos Holdings reported a strategic R&D partnership with Cloudpharm P.C. to study the human gastrointestinal microbiome and launch related products targeting on obesity and other gut-related disorders.
- Missfresh Limited (NASDAQ: MF) shares gained 8.4% to close at $0.2764 after declining around 10% on Thursday.
- Tenax Therapeutics, Inc. (NASDAQ: TENX) gained 6.1% to close at $0.3182.
- Synchronoss Technologies, Inc. (NASDAQ: SNCR) surged 6.1% to close at $1.22.
Losers
- Talaris Therapeutics, Inc. (NASDAQ: TALS) shares dipped 49% to close at $2.30 on Friday. SVB Leerink downgraded Talaris Therapeutics from Outperform to Market Perform and lowered the price target from $21 to $7.
- Agile Therapeutics, Inc. (NASDAQ: AGRX) dropped 45% to close at $0.6404 after the company priced a 26,666,666 share common stock offering at $0.90 per share.
- Kalera Public Limited Company (NASDAQ: KAL) fell 38.8% to close at $3.61.
- Ensysce Biosciences, Inc. (NASDAQ: ENSC) fell 34.5% to close at $0.5690 after jumping around 73% on Thursday.
- Akouos, Inc. (NASDAQ: AKUS) dropped 33.7% to close at $3.11.
- Cryptyde, Inc. (NASDAQ: TYDE) fell 31.5% to close at $1.39.
- MMTec, Inc. (NASDAQ: MTC) fell 29.7% to close at $0.2072.
- ioneer Ltd (NASDAQ: IONR) fell 28.6% to close at $12.58.
- Acutus Medical, Inc. (NASDAQ: AFIB) declined 27.3% to close at $0.8143. Acutus Medical recently announced the commercial launch of its left-heart access products.
- Brickell Biotech, Inc. (NASDAQ: BBI) fell 22.2% to close at $0.0980. Brickell Biotech announced a 1-for-45 reverse stock split.
- Enjoy Technology, Inc. (NASDAQ: ENJY) dropped 21.3% to close at $0.1708.
- Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares declined 21.1% to close at $0.5130 after jumping around 20% on Thursday.
- Benitec Biopharma Inc. (NASDAQ: BNTC) fell 20.3% to close at $0.9250.
- Kohl's Corporation (NYSE: NYSE:KSS) shares declined 19.6% to close at $28.68 after the company called off discussions to sell its business to Franchise Group Inc.
- Evofem Biosciences, Inc. (NASDAQ: EVFM) dropped 19.5% to close at $0.91.
- Miromatrix Medical Inc. (NASDAQ: MIRO) fell 18.1% to close at $3.27.
- Yoshitsu Co., Ltd (NASDAQ: TKLF) dropped 17.8% to close at $1.39.
- Redbox Entertainment Inc. (NASDAQ: RDBX) fell 17.4% to close at $6.11.
- Energy Vault Holdings, Inc. (NYSE: NRGV) dropped 17.3% to close at $8.29.
- Alpha Tau Medical Ltd. (NASDAQ: DRTS) fell 16% to settle at $7.57.
- Celldex Therapeutics, Inc. (NASDAQ: CLDX) fell 15.8% to close at $22.70 after the company presented interim data from its Barzolvolimab Phase 1b study at EAACI 2022.
- RiceBran Technologies (NASDAQ: RIBT) fell 15.4% to settle at $0.5667.
- Doma Holdings Inc. (NYSE: DOMA) dropped 15.4% to close at $0.8714.
- Full House Resorts, Inc. (NASDAQ: FLL) fell 14.6% to settle at $5.19.
- NuCana plc (NASDAQ: NCNA) declined 14.4% to close at $0.6205.
- Provention Bio, Inc. (NASDAQ: PRVB) dropped 14.3% to close at $3.43. The U.S. Food and Drug Administration (FDA) has extended its review period by three months for Provention Bio’s Biologics License Application (BLA) for teplizumab in patients with type 1 diabetes.
- ThermoGenesis Holdings, Inc. (NASDAQ: THMO) fell 13.1% to close at $0.2399.
- Jiuzi Holdings, Inc. (NASDAQ: JZXN) fell 10.2% to close at $0.7880.
- Revelation Biosciences, Inc. (NASDAQ: REVB) fell 6.3% to close at $1.04 after jumping 77% on Thursday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for treatment of allergic rhinitis.
- Micron Technology, Inc. (NASDAQ: NASDAQ:MU) fell 3% to close at $53.65. Micron reported upbeat financial results for its third quarter, but issued weak guidance for its fourth quarter.
Read at Benzinga